Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 1
2020 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma.
Okada T, Fushimi C, Matsuki T, Okamoto I, Sato H, Kondo T, Tokashiki K, Kishida T, Ito T, Yamashita G, Aihara Y, Hanyu K, Kushihashi Y, Masubuchi T, Tada Y, Miura K, Harada Y, Momiyama K, Yamashita T, Omura GO, Takahashi H, Oridate N, Tsukahara K. Okada T, et al. Among authors: kushihashi y. Anticancer Res. 2022 Mar;42(3):1607-1613. doi: 10.21873/anticanres.15635. Anticancer Res. 2022. PMID: 35220258
[Clinical study of smoking cessation clinic subjects].
Shino M, Saito H, Takiguchi S, Kushihashi Y, Suzuki M, Yamada Y, Kadokura Y, Kano M, Suzaki H. Shino M, et al. Among authors: kushihashi y. Nihon Jibiinkoka Gakkai Kaiho. 2011 Aug;114(8):721-5. doi: 10.3950/jibiinkoka.114.721. Nihon Jibiinkoka Gakkai Kaiho. 2011. PMID: 21919308 Japanese.